Rationale and Design for Shiga Microalbuminuria Reduction Trial

NCT00202618 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

160

Enrollment

OTHER

Sponsor class

Conditions

Hypertension
Diabetes Mellitus
Albuminuria

Interventions

DRUG: Valsartan
DRUG: Amlodipine

Sponsor

Shiga University